Maternal RSV vaccination generates high-affinity antibodies that efficiently transfer to infants, providing enhanced passive immunity

Dongxiao Liu, Olivia Posadas, Ashish K. Mishra, Mohamed M. Mire, Mindy Pike, Janet A. Englund, Alisa Kachikis, Surender Khurana · 2026

Read Maternal RSV vaccination generates high-affinity antibodies that efficiently transfer to infants, providing enhanced passive immunity by Dongxiao Liu, Olivia Posadas, Ashish K. Mishra, Mohamed M. Mire, Mindy Pike, Janet A. Englund, Alisa Kachikis, Surender Khurana (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13369169.txt.

Description

Dongxiao Liu and co-authors show that vaccinating mothers against RSV arms their babies in a 2026 study. The virus is the top cause of hospital stays in young children, and a vaccine for pregnant people arrived in 2023. What that shot does to the antibodies a baby inherits had not been mapped in detail.

Fifty-eight unvaccinated and forty-nine vaccinated pregnant people and their infants gave samples. Vaccination lifted virus-killing antibodies against both major strains many times over, and binding antibodies to the vaccine protein rose as well. The antibodies were also better matured, gripping their target more tightly. They crossed the placenta efficiently, though very early preterm babies received a smaller share. The authors read the transfer as strong passive armor for a newborn's first months.

Catalog record

CREATORDongxiao Liu, Olivia Posadas, Ashish K. Mishra, Mohamed M. Mire, Mindy Pike, Janet A. Englund, Alisa Kachikis, Surender Khurana
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13369169

Browse the full library · About the Tower of Babel